3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

A Nutrient/Toxin Interaction Theory of the Etiology and Pathogenesis of Chronic Pain-Fatigue Syndromes

Part II

Pages 93-126 | Published online: 04 Dec 2011

References

  • Bell DS. The Doctor's Guide to Chronic Fatigue Syndrome: Understanding, Treating, and Living with CFIDS. New York: Addison-Wesley; 1995:201–202.
  • Martyn JA, White DA, Gronert GA, et al. Up- and Down-Regulation of Skele-tal Muscle Acetylcholine Receptors. Effects on Neuromuscular Blockers. Anesthe-siology. May 1992;76(5):822–843.
  • McIvor ME. Acute Fluoride Toxicity: Pathophysiology and Management. Drug Saf 1990;5(2):79–85.
  • Kang HK, Bullman TA. Mortality Among U.S. Veterans of the Persian Gulf War. N Engl J Med. 1996;335:1498–1504.
  • Franke J. Ossifications and Calcifications of Muscle and Tendon Insertions in Human Industrial Fluorosis. In: Tsunoda H, Yu M-H eds. Fluoride Research 1985. Amsterdam: Elsevier; 1986:335–339. Studies in Environmental Science; vol. 27.
  • Anand JK, Roberts JT. Chronic Fluoride Poisoning in Man: A Review of the Literature in English (1946-1989) and Indications for Research. Biomed Pharma-cother. 1990;44:417–420.
  • Krishnamachari, KAVR. Skeletal Fluorosis in Humans: A Review of Recent Progress in the Understanding of the Disease. Prog Food Nutr Sci. 1986;10:279–314.
  • Sprott H, Muller A, Heine H. Collagen Crosslinks in Fibromyalgia. Arthritis Rheum. August 1997;40(8):1450–1454.
  • Sharma YD. Effect of Sodium Fluoride on Collagen Cross-Link Precursors. Toxicol Lett. 1982:10(1):97–100.
  • Morris ME. Brain and CSF Magnesium Concentrations During Magnesium Deficit in Animals and Humans: Neurological Symptoms. Magnes Res. 1992;5(4): 303–313.
  • Dure-Smith BA, Farley SM, Linkhart SG, et al. Calcium Deficiency in Fluo-ride-Treated Osteoporotic Patients Despite Calcium Supplementation. J Clin Endo-crinol Metab. January 1996;81(1):269–275.
  • Kleerekoper M, Peterson E, Nelson DA. A Randomized Trial of Sodium Fluo-ride as a Treatment for Postmenopausal Osteoporosis. Osteoporos Int. 1991;1:155–162.
  • Riggs BL, Hodgson SF, O'Fallon WM. Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis. N Engl J Med. 1990; 322:802–809.
  • Abraham GE, Grewal H. A Total Dietary Program Emphasizing Magnesium Instead of Calcium. Effect on the Mineral Density of Calcaneous Bone in Postmeno-pausal Women on Hormonal Therapy. J Reprod Med. 1990;35(5):503–507.
  • Susheela AK, Kharb P. Aortic Calcification in Chronic Fluoride Poisoning: Biochemical and Electronmicroscopic Evidence. Exp Mol PathoL 1990;53:72–80.
  • Zimmerman M. Pathophysiological Mechanisms of Fibromyalgia. Clin J Pain. 1991;7\(suppl 1):58–515.
  • Elert JE, Rantapaa-Dahlqvist SB, Henriksson-Larsen K, et al. Muscle Perfor-mance, Electromyography and Fibre Type Composition in Fibromyalgia and Work-Related Myalgia. Scand J RheumatoL 1992;21(1):28–34.
  • Bennett RM, Cook DM, Clark SR, et al. Hypothalamic-Pituitary-Insulin-Like Growth Factor-1 Axis Dysfunction in Patients with Fibromyalgia. J RheumatoL 1997;24(7):1384–1389.
  • Neeck G, Riedel W. Neuromediator and Hormonal Perturbations in Fibromy-algia Syndrome: Results of Chronic Stress? Baillieres Clin RheumatoL November 1994;8(4):763–775.
  • Crofford LJ, Demitrack MA. Evidence that Abnormalities of Central Neuro-hormonal Systems Are Key to Understanding Fibromyalgia and Chronic Fatigue Syndrome. Rheum Dis Clin North Am. 1996;22(2):267–284.
  • Kaul RD, Susheela AK. The Muscle. In: The Symposium on the Non-Skeletal Phase of Chronic Fluorosis. Fluoride. 1976;9(1):9–18.
  • Simms RW. Is There Muscle Pathology in Fibromyalgia Syndrome? Rheum Dis Clin North Am. May 1996;22(2):245–266.
  • Thomas J, Thomas E, Tomb E. Serum and Erythrocyte Magnesium Con-centrations and Migraine. Magnes Res. June 1992:5(2):127–130.
  • Mauskop A, Altura BM. Role of Magnesium in the Pathogenesis and Treat-ment of Migraines. Clin Neurosci. 1998;5(1):24–27.
  • Grimbergen GW. A Double-Blind Test for Determination of Intolerance to Fluoridated Water (preliminary report). Fluoride. 1974;7:146–152.
  • Standaert FG. Pharmacology of the Neuromuscular Junction. In: Brumback RA, Gerst JAV eds. The Neuromuscular Junction. New York: Futura Publishing Co.;1984:121–294.
  • Dasarathy S, Das TK, Gupta IP, et al. Gastroduodenal Manifestations in Pa-tients with Skeletal Fluorosis. J GastroenteroL June 1996;31(3):333–337.
  • Muller P, Schmid K, Warnecke G., et al. Sodium Fluoride-Induced Gastric Mucosal Lesions: Comparison with Sodium Monofluorophosphate. Z GastroenteroL April 1992;30(4):252–254.
  • Sivri A, Cindas A, Dincer F, et al. Bowel Dysfunction and Irritable Bowel Syndrome in Fibromyalgia Patients. Clin Rheumatol. May 1996;15(3):283–286.
  • Mattson MP. Advances Fuel Alzheimer 's Conundrum. Nat Genet. November 1997;17:254–256.
  • Depoortere H, Francon D, Llopis J. Effects of a Magnesium-Deficient Diet on Sleep Organization in Rats. Neuropsychobiology. 1993;27(4):237–245.
  • Karczmar AG. Brief Presentation of the Story and Present Status of Studies of the Vertebrate Cholinergic System. Neuropsychopharmacology. 1993;9(3):181–199.
  • Mullenix PJ, Denbesten PK, Schunior A., et al. Neurotoxicity of Sodium Fluoride in Rats. Neurotoxicol Teratol, 1995;17(2):169–177.
  • Spittle B. Psychopharmacology of Fluoride: A Review. Int Clin Psychophar-macol. 1994;9:79–82.
  • Demitrack MA. Neuroendocrine Correlates of Chronic Fatigue Syndrome: A Brief Review. J Psychiatr Res. 1997;31(1):69–82.
  • Russell IJ, Vaeroy H, Javors M, et al. Cerebrospinal Fluid Biogenic Amine Metabolites in Fibromyalgia/Fibrositis Syndrome and Rheumatoid Arthritis. Arthri-tis Rheum. May 1992;35(5):550–556.
  • Friedman A, Kaufer D, Shemer J, et al. Pyridostigmine Brain Penetration Un-der Stress Enhances Neuronal Excitability and Induces Early Immediate Transcrip-tional Response. Nat Med. December 1996;2(12):1382–1385.
  • McEwen BS, Magarinos AM. Stress Effects on Morphology and Function of the Hippocampus. Ann N Y Acad Sci. June 21 1997;821:271–284.
  • Janowsky DS, Overstreet DH, Numberger JI Jr. Is Cholinergic Sensitivity a Genetic Marker for the Affective Disorders? Am J Med Genet. 1994;54:335–344.
  • Galland L. Magnesium, Stress and Neuropsychiatric Disorders. Magnes Trace Elem. 1991;10(2-4):287–301.
  • Moldofsky H. Sleep, Neuroimmune and Neuroendocrine Functions in Fibro-myalgia and Chronic Fatigue Syndrome. Adv Neuroimmunol. 1995;5:39–56.
  • Branco J, Atalaia A, Paiva T. Sleep Cycles and Alpha-Delta Sleep in Fibromy-algia Syndrome. J Rheumatol. June 1994;21(6):1113–1117.
  • de Lecea L, Criado JR, Prospero-Garcia O, et al. A Cortical Neuropeptide with Neuronal Depressant and Sleep-Modulating Properties. Nature. May 16 1996; 381:242–245.
  • Jones BE. The Organization of Central Cholinergic Systems and Their Func-tional Importance in Sleep-Waking States. Prog Brain Res. 1993;98:61–71.
  • de Lecea L, del Rio JA, Criado JR, et al. Cortistatin Is Expressed in a Distinct Subset of Cortical Intemeurons. J Neurosci. August 1 1997;17(15):5868–5880.
  • Williams JA, Comisarow J, Day J, et al. State-Dependent Release of Acetyl-choline in Rat Thalamus Measured by in vivo Microdialysis. J Neurosci. September 1994;14(9):5236–5242.
  • Weglicki WB, Dickens BF, Wagner TL, et al. Immunoregulation by Neuro-peptides in Magnesium Deficiency: Ex vivo Effect of Enhanced Substance P Produc-tion on Circulating T Lymphocytes from Magnesium-Deficient Mice. Magnes Res. 1996;9:3–11.
  • Russell IJ, Orr MD, Littman B, et al. Elevated Cerebrospinal Fluid Levels of Substance P in Patients with the Fibromyalgia Syndrome. Arthritis Rheum. Novem-ber 1994;37(11):1593–1601.
  • Kurantsin-Mills J, Cassidy MM, Stafford RE, et al. Marked Alterations in Cir-culating Inflammatory Cells During Cardiomyopathy Development in a Magnesium-Deficient Rat Model. Br . I Nutr. November 1997;78(5):845–855.
  • Weglicki WB, Phillips TM. Pathobiology of Magnesium Deficiency: A Cyto-kine/Neurogenic Inflammation Hypothesis. Am .1 Physiol. September 1992;263(3 pt 2): R734–R737.
  • Eisinger J, Zakarian H, Pouly E, et al. Protein Peroxidation, Magnesium Defi-ciency and Fibromyalgia. Magnes Res. 1996;9(4):313–316.
  • Weglicki WB, Mak IT, Kramer JH, et al. Role of Free Radicals and Substance P in Magnesium Deficiency. Cardiovasc Res. 1996;31:677–682.
  • Galland L. Magnesium and Immune Function: An Overview. Magnesium. 1988;7:290–299.
  • Karlsson H, Nassberger L. In vitro Metabolic Inhibition of the Human Lym-phocyte: Influence on the Expression of Interleukin-2 Receptors. Immunol Cell Biol. October 1992;70(5):309–313.
  • Domingo E. RNA Virus Evolution, Population Dynamics, and Nutritional Status. Biol Trace Elem Res. January 1997;56(1):23–30.
  • Lichodziejewska B, Klos J, Rezler J, et al. Clinical Symptoms of Mitral Valve Prolapse Are Related to Hypomagnesemia and Attenuated by Magnesium Supple-mentation. Am .1 Cardiol. March 15 1997;79(6):768–772.
  • Pang X, Marchand J, Sant GR, et al. Increased Number of Substance P Posi-tive Nerve Fibers in Interstitial Cystitis. Br .1 Urol. June 1995;75(6):744–750.
  • Clauw DJ, Schmidt M, Radulovic D, et al. The Relationship Between Fibro-myalgia and Interstitial Cystitis. .1 Psychiatr Res. January-February 1997;31(4125–131.
  • Becking GC. Hepatic Drug Metabolism in Iron-, Magnesium-, and Potassium-Deficient Rats. Fed Proc. November 1976;35(13):2480–2485.
  • Ziem G, McTamney J. Profile of Patients with Chemical Injury and Sensitiv-ity. Environ Health Perspect. March 1997;105\(suppl 2):417–436.
  • McFadden SA. Phenotypic Variation on Xenobiotic Metabolism and Adverse Environmental Response: Focus on Sulfur-Dependent Detoxification Pathways. Tox-icology. July 1996;111(1-3):43–65.
  • Buchwald D, Garrity D. Comparison of Patients with Chronic Fatigue Syn-drome, Fibromyalgia, and Multiple Chemical Sensitivities. Arch Intern Med. Sep-tember 26 1994;154(18):2049–2053.
  • Galland L. Biochemical Abnormalities in Patients with Multiple Chemical Sensitivities. Occup Med. October 1987;2(4):713–720.
  • Salvaggio JE, Terr Al. Multiple Chemical Sensitivity Multiorgan Dyesthesia, Multiple Symptom Complex, and Multiple Confusion: Problems in Diagnosing the Patient Presenting with Unexplained Multisystemic Symptoms. Crit Rev Toxicol. November 1996;26(6):617–631.
  • Hutchins JB, Hollyfield JG. Human Retinas Synthesize and Release Acetyl-choline. .1 Neurochem. July 1986;47(1):81–87.
  • Knave B, Tengroth B, Voss M. Age and Sex Distribution of Some Retinal Macular Diseases: Senile and Presenile Macular Degeneration and Central Serous Retinitis. Acta Ophthalmol SuppL 1984;161:95–103.
  • Ciarallo L, Sauer AH, Shannon MW. Intravenous Magnesium Therapy for Moderate to Severe Pediatric Asthma: Results of a Randomized, Placebo-Controlled Trial. J Pediatr. December 1996;129(6):809–814.
  • Ziment I. Alternative Therapies for Asthma. Curr Opin Pulm Med. January 1997;3(1):61–71.
  • Hill J, Micklewright A, Lewis S, et al. Investigation of the Effect of Short-Term Change in Dietary Magnesium Intake in Asthma. Eur Respir J. October 1997;10(10):2225–2229.
  • Trivedi N, Mithal A, Gupta SK, et al. Reversible Impairment of Glucose Tol-erance in Patients with Endemic Fluorosis. Diabetologia. 1993;36:826–828.
  • Vinals F, Testar X, Palacin M, et al. Inhibitory Effect of Fluoride on Insulin Receptor Autophosphorylation and Tyrosine Kinase Activity. Biochem J. 1993;291: 615–622.
  • Vinals F, Camps M, Testar X, et al. Effect of Cations on the Tyrosin Kinase Activity of the Insulin Receptor: Inhibition by Fluoride is Magnesium Dependent. Mol Cell Biochem. 1997;171:69–73.
  • Frankel BL, Patten BM, Gillin JC. Restless Legs Syndrome. Sleep-Electroen-cephalographic and Neurologic Findings. JAMA. December 2 1974;230(9):1302–1303.
  • Popoviciu L, Asgian B, Delast-Popoviciu D, et al. Clinical, EEG, Electromyo-graphic and Polysomnographic Studies in Restless Legs Syndrome Caused by Mag-nesium Deficiency. Rom J Neurol Psychiatry. January 1993;31(1):55–61.
  • Fox MRS. Effects of Dietary Mineral Levels on Metabolism and Require-ments. Neurotoxicology. 1983;4(3):113–120.
  • Malleson PN, al Matar M, Petty RE. Idiopathic Musculoskeletal Pain Syn-dromes in Children. J Rheumatol. November 1992;19(11):1786–1789.
  • Oberklaid F, Amos D, Liu C, et al. "Growing Pains": Clinical and Behavioral Correlates in a Community Sample. J Dev Behav Pediatr April 1997;18(2):102–106.
  • Weiner SR. Growing Pains. Am Fam Physician. 1983;27(1):189–191.
  • Natelson BH. NJ Center for Environmental Hazards Research. FEDRIP Data-base, National Technical Information Service (NTIS); 1996.
  • Bradley LA, Alarcon GS. Fibromyalgia. In: Koopman WJ ed. Arthritis and Allied Conditions: A Textbook of Rheumatology. New York: Williams and Wilkins; 1997.
  • Michel IN, Suttie JAV, Sunde ML. Fluorine Deposition in Bone as Related to Physiological State. Poult Sci. 1984;63(7):1407–1411.
  • Vikoren T, Stuve G. Fluoride Exposure and Selected Characteristics of Eggs and Bones of the Herring Gull (Larus argentatus) and the Common Gull (Larus ca-nus). J Wildl Dis. April 1996;32(2):190–198.
  • Smith FA, Gardner DE, Hodge HC. Age Increase in Fluoride Content in Hu-man Bone. Fed Proc. 1953;12:368.
  • Bixler D, Muhler JC, Shafer WG. Experimental Dental Caries. V. The Effects of Desalivation and Castration on Caries and Fluorine Storage in the Rat. J Nutr. 1954;52:345–353.
  • Messer HH. Fluorine. In: Frieden E ed. Biochemistry of the Essential Ultra-trace Elements. New York: Plenum Press; 1984:55–87.
  • Vogel JA, Friedl, KE. Body Fat Assessment in Women. Special Consider-ations. Sports Med. April 1992;13(4):245–269.
  • Russell U. Neurohormonal Aspects of Fibromyalgia Syndrome. Rheum Dis Clin North Am. 1989;15:149–168.
  • Jezova D, Jurankova E, Mosnarova A, et al. Neuroendocrine Reponse During Stress with Relation to Gender Differences. Acta Neurobiol Exp. 1996;56:779–785.
  • Ramsay AM. Myalgic Encephalomyelitis and Postviral Fatigue States: The Saga of Royal Free Disease. 2nd Ed. London: Gower Medical Publishing; 1988.
  • Manocha SL, Warner H, Olkowski, ZL. Cytochemical Response of Kidney, Liver and Nervous System to Fluoride Ions in Drinking Water. Histochem J. 1975;7:343–355.
  • Buskila D, Neumann L, Vaisberg G, et al. Increased Rates of Fibromyalgia Following Cervical Spine Injury. Arthritis Rheum. March 1997;40(3):446–452.
  • Kroenke K, Koslowe P, Roy M. Symptoms in 18,495 Persian Gulf War Veter-ans. Latency of Onset and Lack of Association with Self-Reported Exposures. J Oc-cup Environ Med. June 1998;40(6):520–528.
  • Mukhopadhyay P, Chakraborty S, Mukherjee S. Postcardiac Injury Rheuma-tism. J Assoc Physicians India. June 1995;43(6):388–390.
  • Friis S, Mellemkjaer L, McLaughlin JK, et al. Connective Tissue Disease and Other Rheumatic Conditions Following Breast Implants in Denmark. Ann Plast Surg. July 1997;39(1):1–8.
  • Beisel WR. Herman Award Lecture, 1995: Infection-Induced Malnutri-tion-From Cholera to Cytokines. Am J Clin Nutr. October 1995;62(4):813–819.
  • Levine PH. Epidemiologic Advances in Chronic Fatigue Syndrome. J Psy-chiatr Res. January-February 1997;31(1):7–18.
  • Corbridge TC, Hall JB. The Assessment and Management of Adults with Sta-tus Asthmaticus. Am J Respir Grit Care Med. May 1995;151(5):1296–1316.
  • Skobeloff EM, Spivey WH, Silverman R, et al. The Effect of the Menstrual Cycle on Asthma Presentations in the Emergency Department. Arch Intern Med. Sep-tember 9 1996;156(16):1837–1840.
  • Hosseini J, Firuzian F, Feely J. Ethnic Differences in the Frequency Distribu-tion of Serum Cholinesterase Activity. Ir J Med Sci. January 1997;166(1):10–12.
  • Leone NC, Martin AE, Minoguchi G, et al. Fluorides and General Health. In: Fluorides and Human Health. Geneva: World Health Organization; 1970:273–321.
  • Selwitz RH. Strategies for Improving Methods of Assessing Fluoride Accu-mulation in Body Fluids and Tissues. Adv Dent Res. 1994;8(1):111–112.
  • National Research Council Committee on Biologic Effects of Atmospheric Pollutants. Fluorides. Washington, DC: National Academy of Sciences; 1971.
  • Cox IM, Campbell MJ, Dowson D. Red Blood Cell Magnesium and Chronic Fatigue Syndrome. Lancet. 1991;337:757–760.
  • Abraham GE, Flechas JD. Management of Fibromyalgia: Rationale for the Use of Magnesium and Malic Acid. J Nutr Med. 1992;3:49–59.
  • Russell IJ, Michalek JE, Flechas JD, et al. Treatment of Fibromyalgia Syn-drome with Super Malic: A Randomized, Double-Blind, Placebo Controlled, Cross-over Pilot Study. J Rheumatol. 1995;22(5):953–958.
  • Shimonovitz S, Patz D, Ever-Hadani P, et al. Umbilical Cord Fluoride Serum Levels May Not Reflect Fetal Fluoride Status. J Perinat Med. 1995;23(4):279–282.
  • Brambilla E, Belluomo G, Malerba A, et al. Oral Administration of Fluoride in Pregnant Women, and the Relation Between Concentration in Maternal Plasma and in Amniotic Fluid. Arch Oral Biol. 1994;39(11):991–994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.